Onkologie. 2013:7(6):281-285

Stereotactic radiotherapy and radiosurgery of primary brain tumors

Hana Doleželová1, Petr Pospíšil1, Pavel Šlampa1, Irena Čoupková1, Jan Garčič2, Pavel Fadrus3, Tomáš Svoboda4, Iveta Selingerová5, Ivana Horová5
1 Klinika radiační onkologie LF MU a MOÚ Brno

We analysed retrospectively our treatment of primary brain tumors using stereotactic radiotherapy and radiosurgery.

Methods: Patients underwent CT and MR examinations. Target volume and technique were planned in BrainLab system. Patients were

irradiated on X knife. Radiosurgery was apllied with fixation using stereotactic frame. Stereotactic mask was used in cases of stereotactic

radiotherapy. Statistical processing was performed at Department of mathematics and statistics, Faculty of Science, Masaryk university Brno.

Results: 101 paients were included in our study. In the most of cases there were diagnosis of meningeoma and high-grade glioma.

Median follow up was 22,4 months. Median of dose of radiosurgery was 18 Gy. Patients, whose underwent stereotactic radiotherapy,

were median of doses 25 Gy. Treatment toxicity was low. Stable disease was recorded in 68 % of cases, partial remission achieved in 10 %

patients and one patient had the complete remission.

Conclusion: Results of our study are comparable with results other publicated studies. Stereotactic treatment irradiation has the important

role in the treatment of brain tumors.

Keywords: radiosurgery, stereotactic radiotherapy, brain tumors

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doleželová H, Pospíšil P, Šlampa P, Čoupková I, Garčič J, Fadrus P, et al.. Stereotactic radiotherapy and radiosurgery of primary brain tumors. Onkologie. 2013;7(6):281-285.
Download citation

References

  1. www.NCCN.org.
  2. Šlampa P, a kol. Radiační onkologie v praxi. 3. aktualizované vydání, 2011.
  3. Šimonová G, Novotný J jr. Stereotaktická radiochirurgie a radioterapie, 413-425 im Šlampa P, Petera J: Radiační onkologie, Galén 2007.
  4. Liščák R, a kol. Radiochirurgie gamanožem. Principy a neurochirurgické aplikace, Grada 2009: 77-92.
  5. Collet D. Modelling survival datat in medici research. Chapman and Hall/CRC 1999.
  6. El Majdoub F, Elawady M, Bührle C, et al. ?MLC-LINAC radiosurgery for intracranial meningeomas: of komplex shape. Acta Neurochir (Wien) 2012 Apr; 154 (4): 599-604. Go to original source... Go to PubMed...
  7. Pollock BE, Stafford SL, Link MJ, et al. Single-fraction Radiosurgery for Presumed Intracranial Meningiomas: Efficacy and Complications from a 22-Year Experience. Int J Radiat Oncol Biol Phys. 2012 Aug 1; 83 (5): 1414-1418. Go to original source... Go to PubMed...
  8. Attia A, Chan MD, Mott RT, et al. Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery. J Neurooncol. 2012 May; 108 (1): 179-185. Go to original source... Go to PubMed...
  9. Minniti G, Amicheti M, Enrici RM, et al. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol. 2009; 4: 42. Go to original source... Go to PubMed...
  10. Metellus P, Regis J, Muracciole X, et al. Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery. 2005; 57: 873-886. Go to original source... Go to PubMed...
  11. Torres RC, Frighetto L, De Salles AA, et al. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurg Focus. 2003 May 15; 14 (5): e5. Go to original source... Go to PubMed...
  12. Lo SS, Cho KH, Hall WA, et al. Single dose versus fractionated stereotactic radiotherapy for meningiomas. Can J Neurol Sci. 2002; 29: 240-248. Go to original source... Go to PubMed...
  13. Lakomý R, Fadrus P, Šlampa P, et al. Výsledky multimodální léčby glioblastoma multiforme: Konsekutivní série 86 pacientů diagnostikovaných v letech 2003-2009, Klinická onkologie, 24, 2011; 2: 112-120.
  14. Biswas T, Okunieff P, Schell MC, et al. Stereotactic radiosurgery for glioblastoma. Retospective analysis. Radiation Oncology 2009; 4: 11. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.